NKTR Deadline: Rosen Law Firm Urges Nektar Therapeutics (NASDAQ: NKTR) Stockholders to Contact the Firm for Information About Their RightsApril 27, 2026
Share Twitter Facebook LinkedIn Email The president’s business empire — once known for its hotels and golf courses — has aggressively expanded into the world of cryptocurrencies during his first year back in the White House.Read More